Literature DB >> 8791246

Increased density of senile plaques (SP), but not neurofibrillary tangles (NFT), in non-demented individuals with the apolipoprotein E4 allele: comparison to confirmed Alzheimer's disease patients.

D L Sparks1, S W Scheff, H Liu, T Landers, F Danner, C M Coyne, J C Hunsaker.   

Abstract

The apolipoprotein E genotype and cortical senile plaque (SP) and cortical and hippocampal neurofibrillary tangle (NFT) densities were determined in non-demented individuals and neuropathologically confirmed AD patients. The non-demented population was further subdivided according to presence or absence of pathologically established critical coronary artery disease (cCAD), hypertension (HyperT), or neither (non-heart disease; non-HD). The apolipoprotein E4 (APOE4) allele incidence and dose frequencies were increased in the AD, cCAD and HyperT groups compared to the non-HD controls. The mean number of SP and NFT was significantly increased with the presence of the APOE4 allele within the entire population. After grouping the non-demented subjects according to cardiac status, SP but not NFT density was increased among those individuals with the APOE4 genotype. In HyperT, the increased density of SP also correlated to the APOE4 allele dose frequency. The density of SP and NFT was increased in all regions of AD brain compared to all other non-demented groups, but no significant difference was found between AD patients with or without an APOE4 allele. These two AD groups were age-matched, but could not be matched for disease duration. The data suggest a relationship between heart disease, APOE4 genotype and the presence of SP regardless of cognitive status.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8791246     DOI: 10.1016/0022-510x(96)00008-1

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  10 in total

1.  Blood pressure is associated with higher brain amyloid burden and lower glucose metabolism in healthy late middle-age persons.

Authors:  Jessica B S Langbaum; Kewei Chen; Lenore J Launer; Adam S Fleisher; Wendy Lee; Xiaofen Liu; Hillary D Protas; Stephanie A Reeder; Daniel Bandy; Meixiang Yu; Richard J Caselli; Eric M Reiman
Journal:  Neurobiol Aging       Date:  2011-08-06       Impact factor: 4.673

2.  Apolipoprotein E allelotype is associated with neuropathological findings in Alzheimer's disease.

Authors:  Neena Theresa Kumar; Knut Liestøl; Else Marit Løberg; Henrik Mikael Reims; Jan Mæhlen
Journal:  Virchows Arch       Date:  2015-04-22       Impact factor: 4.064

3.  Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.

Authors:  L F Lue; Y M Kuo; A E Roher; L Brachova; Y Shen; L Sue; T Beach; J H Kurth; R E Rydel; J Rogers
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

4.  Neuropsychiatric symptoms and the APOE genotype in Alzheimer's disease.

Authors:  Marina Del Prete; Simona Spaccavento; Angela Craca; Pietro Fiore; Paola Angelelli
Journal:  Neurol Sci       Date:  2009-07-10       Impact factor: 3.307

5.  Amyloid mediates the association of apolipoprotein E e4 allele to cognitive function in older people.

Authors:  D A Bennett; J A Schneider; R S Wilson; J L Bienias; E Berry-Kravis; S E Arnold
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-09       Impact factor: 10.154

6.  Decreases in plasma A beta 1-40 levels with aging in non-demented elderly with ApoE-epsilon 4 allele.

Authors:  N Pomara; B Shao; T Wisniewski; P D Mehta
Journal:  Neurochem Res       Date:  1998-12       Impact factor: 3.996

7.  Hypertension and the risk of mild cognitive impairment.

Authors:  Christiane Reitz; Ming-Xin Tang; Jennifer Manly; Richard Mayeux; José A Luchsinger
Journal:  Arch Neurol       Date:  2007-12

8.  The effect of APOE-epsilon4 on dementia is mediated by Alzheimer neuropathology.

Authors:  James A Mortimer; David A Snowdon; William R Markesbery
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Apr-Jun       Impact factor: 2.703

9.  A reduced astrocyte response to β-amyloid plaques in the ageing brain associates with cognitive impairment.

Authors:  Ryan Mathur; Paul G Ince; Thais Minett; Claire J Garwood; Pamela J Shaw; Fiona E Matthews; Carol Brayne; Julie E Simpson; Stephen B Wharton
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

10.  Role of Hypertension in Aggravating Abeta Neuropathology of AD Type and Tau-Mediated Motor Impairment.

Authors:  C Díaz-Ruiz; J Wang; H Ksiezak-Reding; L Ho; X Qian; N Humala; S Thomas; P Martínez-Martín; G M Pasinetti
Journal:  Cardiovasc Psychiatry Neurol       Date:  2009-09-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.